1-2 of 2
Hong-Mei Jing
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Glofitamab Monotherapy Demonstrates High Complete Response Rates and Manageable Safety in Chinese Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma and ≥2 Prior Therapies

Yu-Qin Song, Hui-Lai Zhang, Hui-Qiang Huang, Qing-Yuan Zhang, Hong-Mei Jing, Chao Wang, Chun Wu, Dong-Hang Li, Yu Dai, Kathryn Humphrey, Jun Zhu
Journal: Blood
Blood (2022) 140 (Supplement 1): 12050–12051.
https://doi.org/10.1182/blood-2022-157544
Published: 2022
Journal Articles

Higher Rates of t(11;18) in Chinese Patients with Transformed Type of MALT Lymphoma Suggest Novel Pathways for Progression of the Disease.

Xiao-Yan Ke, MD, PhD, Jing Wang, Ling-Zhi Zhao, Zi-Fen Gao, Fei Dong, Lin Shi, Hong-Mei Jing, M.D., Ji-Jun Wang, Wei Zhao, Xiao-Feng Yang
Journal: Blood
Blood (2007) 110 (11): 2621.
https://doi.org/10.1182/blood.V110.11.2621.2621
Published: 2007